[Cu(dimethylbpy)2Cl]PF6 Complex as an Antibacterial Agent
- Authors: Satarzadeh N.1,2, Asadipour A.3, Amirheidari B.2,4
-
Affiliations:
- Student Research Committee, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
- Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
- Department of Medicinal Chemistry, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
- Pharmaceutical Sciences and Cosmetic Products Research Center, Kerman University of Medical Sciences, Kerman, Iran
- Issue: Vol 22, No 5 (2024)
- Section: Medicine
- URL: https://rjeid.com/2211-3525/article/view/642333
- DOI: https://doi.org/10.2174/0122113525294195240415061854
- ID: 642333
Cite item
Full Text
Abstract
Background:Antibiotic resistance is currently considered a major public health problem. This subject underscores the critical need for novel and enhanced antibacterial agents with a novel molecular structure and a new target to prevent cross-resistance. Copper exhibits antimicrobial properties by disrupting bacterial cell membranes and interfering with cellular processes. Copper complexes enhance these properties, offering improved stability and targeted antibacterial activity. Their ability to release copper ions can gradually enhance efficacy while minimizing toxicity. Therefore, investigating the antibacterial properties of new copper complexes is of significance.
Methods:In this study, the antibacterial activity of [Cu(dimethylbpy)2Cl]PF6 complex was examined against several Gram-negative bacteria, Pseudomonas aeruginosa, Escherichia coli, klebsiella pneumoniae, salmonella typhi and Gram-positive bacteria Staphylococcus aureus and Micrococcus luteus by determining the minimum inhibitory concentration (MIC). The antibacterial activity of [Cu(dimethylbpy)2Cl]PF6 complex and Gentamicin (as standard compound) were determined using the microplate method. All concentrations were repeated three times. The minimum inhibitory concentration was determined both using the unaided eye and absorbance at 490 nm.
Results:The [Cu(dimethylbpy)2Cl]PF6 complex showed higher antibacterial activity against Gram-positive bacteria than Gram-negative bacteria. Among the assayed bacterial strains, the complex was most effective against Micrococcus luteus and Staphylococcus aureus with MIC values of 100 and 250 µM, respectively.
Conclusion:This complex displayed antimicrobial potential against some bacterial strains. Therefore, this complex may be used as an effective antibacterial agent in the treatment of infection caused by some bacterial strains, but further research is needed.
About the authors
Naghmeh Satarzadeh
Student Research Committee, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran; Departmentof Pharmaceutical Biotechnology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
Email: info@benthamscience.net
Ali Asadipour
Departmentof Medicinal Chemistry, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
Email: info@benthamscience.net
Bagher Amirheidari
Departmentof Pharmaceutical Biotechnology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran; Pharmaceutical
Sciences and Cosmetic Products Research Center, Kerman University of Medical Sciences, Kerman, Iran
Author for correspondence.
Email: info@benthamscience.net
Supplementary files
